Analyst Reco. Onconetix, Inc.

Equities

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-07-04 pm EDT			5-day change	1st Jan Change
0.1561 ^USD	-2.25%		-6.64%	-21.16%

Jun. 14	Onconetix, Inc. Announces the Appointment of Karina M. Fedasz as Interim Chief Financial Officer	CI
May. 20	Tranche Update on Onconetix, Inc.'s Equity Buyback Plan announced on November 10, 2022.	CI

Maxim Downgrades Blue Water Biotech to Hold From Buy	23-09-13	MT
HC Wainwright Adjusts Price Target on Blue Water Biotech to $9 From $7, Maintains Buy Rating	23-04-26	MT
Maxim Starts Blue Water Vaccines at Buy With $4 Price Target	22-12-08	MT

No results for this search